Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis

Journal of Clinical Oncology

Volumn 24, Issue 18, 2006, Pages 2743-2749

  Rapiti, Elisabetta ^a   Verkooijen, Helena M ^a   Vlastos, Georges ^a   Fioretta, Gerald ^a   Neyroud Caspar, Isabelle ^a   Sappino, André Pascal ^a   Chappuis, Pierre O ^a   Bouchardy, Christine ^a  

^a GENEVA CANCER REGISTRY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROGNOSIS; RISK REDUCTION; SWITZERLAND; BONE TUMOR; BREAST TUMOR; MASTECTOMY; MIDDLE AGED; PATHOLOGY; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; BREAST NEOPLASMS; FEMALE; HUMANS; MASTECTOMY; MIDDLE AGED; NEOPLASM METASTASIS; SURVIVAL ANALYSIS;

EID: 33745530973     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.04.2226     Document Type: Article

References (30)

1. Wood WC, Muss HB, Solin LJ, et al: Cancer of the breast, in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer Principles & Practice of Oncology. Philadelphia, PA, Lippincott Williams & Wilkins, 2005, pp 1453-1462
2. Falkson G, Holcroft C, Gelman RS, et al: Ten-year follow-up study of premenopausal women with metastatic breast cancer: An Eastern Cooperative Oncology Group study. J Clin Oncol 13:1453-1458, 1995
3. Donegan WL: Stage IV carcinoma, in Donegan WL, Spratt JS (eds): Cancer of the Breast. Philadelphia, PA, Saunders, Elsevier Science, 2002, pp 597-600
4. Bernard-Marty C, Cardoso F, Piccart MJ: Facts and controversies in systemic treatment of metastatic breast cancer. Oncologist 9:617-632, 2004
5. Hortobagyi GN: Treatment of breast cancer. N Engl J Med 339:974-984, 1998
6. Singletary SE, Walsh G, Vauthey JN, et al: A role for curative surgery in the treatment of selected patients with metastatic breast cancer. Oncologist 8:241-251, 2003
7. National Health and Medical Research Council: Clinical practice guidelines for the management of advanced breast cancer. Prepared by the iSource National Breast Cancer Centre Advanced Breast Cancer Working Group. Endorsed January 2001. www .nhmrc.gov.au/publications/synopses/cp76syn.htm
8. National Cancer Institute: Breast Cancer (PDQ): Treatment. Stage IIIB, inoperable IIIC, IV, recurrent, and metastatic breast cancer. www.cancer.gov/cancertopics/pdq/treatment/breast/HealthProfessional/page8
9. Canadian Cancer Society: Canadian Cancer Encyclopedia. Breast cancer. Treatment by stage. Stage IV breast cancer - treatment. Stage IV (any T, any N, M1). http://info.cancer.ca/E/CCE/cceexplorer.ascp?tocid=10
10. Coffey JC, Wang JH, Smith MJ, et al: Excisional surgery for cancer cure: Therapy at a cost. Lancet Oncol 4:760-768, 2003
11. Baum M, Demicheli R, Hrushesky W, et al: Does surgery unfavourably perturb the "natural history" of early breast cancer by accelerating the appearance of distant metastases? Eur J Cancer 41:508-515, 2005
12. Khan SA, Stewart AK, Morrow M: Does aggressive local therapy improve survival in metastatic breast cancer? Surgery 132:620-626, 2002
13. Bouchardy C: Switzerland, Geneva. In Parkin DM, Whelan SL, Ferlay J, et al (eds): Cancer Incidence in Five Continents, Vol VII. Lyon, France, International Agency for Research on Cancer, 1997, pp 666-669
14. WHO: ICD-O International Classification of Diseases for Oncology (ed 1). Geneva, Switzerland, World Health Organization, 1976
15. UICC: TNM Classification of Malignant Tumors. New York, NY, International Union Against Cancer, 2002
16. Bouchardy C, Schuler G, Minder C, et al: Cancer risk by occupation and socioeconomic group among men: A study by the Association of Swiss Cancer Registries. Scand J Work Environ Health 28:1-88, 2002 (suppl 1)
17. Greenwood M: The Natural Duration of Cancer. London, United Kingdom, Her Majesty's Stationary Office, 1926
18. Hill C, Com-Nougué C, Kramar A, et al: Analyse Statistique des Données de Survie. Paris, France, Médecine-sciences Flammarion, 1990
19. O'Reilly MS, Holmgren L, Shing Y,: Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315-328, 1994
20. Flanigan RC, Salmon SE, Blumenstein BA, et al: Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 345:1655-1659, 2001
21. Rosen SA, Buell JF, Yoshida A, et al: Initial presentation with stage IV colorectal cancer: How aggressive should we be? Arch Surg 135:530-534, 2000
22. Hallissey MT, Allum WH, Roginski C, et al: Palliative surgery for gastric cancer. Cancer 62:440-444, 1988
23. Essner R, Lee JH, Wanek LA, et al: Contemporary surgical treatment of advanced-stage melanoma. Arch Surg 139:961-966, 2004
24. Cristofanilli M, Budd GT, Ellis MJ, et al: Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351:781-791, 2004
25. Cristofanilli M, Hayes DF, Budd GT, et al: Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 23:1420-1430, 2005
26. Sherry MM, Greco FA, Johnson DH, et al: Metastatic breast cancer confined to the skeletal system: An indolent disease. Am J Med 81:381-386, 1986
27. Briasoulis E, Karavasilis V, Kostadima L, et al: Metastatic breast carcinoma confined to bone: Portrait of a clinical entity. Cancer 101:1524-1528, 2004
28. Kang Y, Siegel PM, Shu W, et al: A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3:537-549, 2003
29. Fidler IJ: The pathogenesis of cancer metastasis: The 'seed and soil' hypothesis revisited. Nat Rev Cancer 3:453-458, 2003
30. Goodison S, Kawai K, Hihara J, et al: Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein. Clin Cancer Res 9:3808-3814, 2003